Found 43 matching trials
A Phase II Study of Adjuvant Durvalumab Combined With GEMOX/GC Chemotherapy Followed by Lenvatinib Versus Capecitabine in Biliary Tract Cancer. PHASE2 This study is designed as a prospective, randomized, open-label, phase II c...
Show More Location
Chinese Academy of Medical Sciences & Peking Union Medical College Hospital (CAMS&PUMCH), Beijing, 100730
Learn More & Join Trial
Precision Adjuvant Therapy After Surgery for Hepatocellular Carcinoma PHASE4 Vessels that encapsulate tumor clusters (VETC) is an invasive metastatic fa...
Show More Location
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
Learn More & Join Trial
Postoperative Adjuvant Therapy of HCC Based on PD-1 N/A For the treatment of hepatocellular carcinoma, liver resection is still one...
Show More Location
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Learn More & Join Trial
Study of MK-4830 as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-4830-001) PHASE1 This study consists of several parts: dose escalation, dose expansion, dose...
Show More Location
University of California at San Francisco ( Site 0004)
Learn More & Join Trial
Efficacy and Safety of Pembrolizumab (MK-3475) With Lenvatinib (E7080/MK-7902) vs. Docetaxel in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) and Progressive Disease (PD) After Platinum Doublet Chemotherapy and Immunotherapy (MK-7902-008/E7080-G000-316/LEAP-008) PHASE3 This study will evaluate the efficacy and safety of pembrolizumab (MK-3475)...
Show More Location
Comprehensive Blood & Cancer Center [Bakersfield, CA] ( Site 1604)
Learn More & Join Trial
Tislelizumab Monotherapy or Combined With Lenvatinib as Neoadjuvant Therapy for Resectable Hepatocellular Carcinoma. PHASE2 This is a phase II prospective study to evaluate the safety and efficacy of...
Show More Location
Tianjin Medical University Cancer Institute & Hospital
Learn More & Join Trial
Pembrolizumab and Lenvatinib for the Treatment of Serous Ovarian Cancer Patients PHASE2 This pilot clinical trial studies the effect of pembrolizumab and lenvatini...
Show More Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Learn More & Join Trial
A Study of Tegavivint (BC2059) in Patients With Advanced Hepatocellular Carcinoma PHASE1 This study will be conducted in 2 parts. The first part is a phase 1 single...
Show More Learn More & Join Trial
Study of Tislelizumab, Pamiparib, and Other Investigational Agents in Participants With Advanced Malignancies PHASE3 This is an open-label, multicenter, extension study to evaluate the long-te...
Show More Location
Mount Sinai Medical Center Braman Comprehensive Cancer Center
Learn More & Join Trial
A Multicenter Registry Study on Stage III Hepatocellular Carcinoma in Unresectable CNLC Liver Cancer N/A This study is a multicenter, registered research aimed at evaluating the ef...
Show More Location
Multiple Locations
Learn More & Join Trial